Asia ranks second in Prostate cancer incidence accounting for over a quarter of the global incident cases and has the world’s highest number of deaths due to Prostate cancer in 2020.
Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report
Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published
Read more